Beswick Daniel M, Ramadan Hassan, Baroody Fuad M, Hwang Peter H
Department of Otolaryngology, Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
Am J Rhinol Allergy. 2016 Nov 1;30(6):418-423. doi: 10.2500/ajra.2016.30.4373.
The management of pediatric chronic rhinosinusitis (PCRS) is evolving.
To assess current practice patterns of members of the American Rhinologic Society (ARS) in managing PCRS.
A 27-item Web-based survey on treatment of PCRS was electronically distributed to the ARS membership.
The survey was completed by 67 members, 40% of whom had completed a rhinology fellowship. The most frequently used medical therapies as part of initial treatment for PCRS were nasal saline solution irrigation, (90%), topical nasal steroids (93%), oral antibiotics (52%), and oral steroids (20%). For initial surgical therapy, 90% performed adenoidectomy; in addition, 31% also performed sinus lavage, 17% performed balloon catheter dilation (BCD), and 17% performed endoscopic sinus surgery (ESS). Sixty percent performed adenoidectomy before obtaining computed tomography imaging. When initial surgical treatment failed, 85% performed traditional ESS. In patients with pansinusitis, 50% of the respondents performed frontal sinusotomy and 70% performed sphenoidotomy. BCD was not frequently used; overall, 66% never or rarely used it, 20% sometimes used it, 12% usually used it, and 3% always or almost always used BCD.
Most aspects of PCRS management among ARS members were aligned with published consensus statements. Adenoidectomy was almost always included as part of first-line surgical treatment but was also combined with adjunctive surgical procedures with moderate frequency. ESS was performed by a minority of rhinologists as a primary procedure for medically refractory PCRS but was favored when previous surgery failed. BCD was uncommonly used in PCRS.
小儿慢性鼻窦炎(PCRS)的治疗方法正在不断发展。
评估美国鼻科学会(ARS)成员在治疗PCRS方面的当前实践模式。
通过网络向ARS成员发放了一份关于PCRS治疗的包含27个条目的调查问卷。
67名成员完成了该调查,其中40%完成了鼻科学 fellowship。作为PCRS初始治疗的一部分,最常用的药物治疗方法是鼻腔生理盐水冲洗(90%)、局部鼻用类固醇(93%)、口服抗生素(52%)和口服类固醇(20%)。对于初始手术治疗,90%的人进行了腺样体切除术;此外,31%的人还进行了鼻窦灌洗,17%的人进行了球囊导管扩张术(BCD),17%的人进行了鼻内镜鼻窦手术(ESS)。60%的人在获得计算机断层扫描成像之前就进行了腺样体切除术。当初始手术治疗失败时,85%的人进行了传统的ESS。在全鼻窦炎患者中,50%的受访者进行了额窦切开术,70%的人进行了蝶窦切开术。BCD使用并不频繁;总体而言,66%的人从未或很少使用它,20%的人有时使用,12%的人通常使用,3%的人总是或几乎总是使用BCD。
ARS成员在PCRS管理的大多数方面与已发表的共识声明一致。腺样体切除术几乎总是作为一线手术治疗的一部分,但也会以中等频率与辅助手术相结合。少数鼻科医生将ESS作为药物难治性PCRS的主要手术方法,但在前次手术失败时更受青睐。BCD在PCRS中使用不常见。